Elsevier

Brain Research

Volume 336, Issue 1, 10 June 1985, Pages 27-31
Brain Research

Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve

https://doi.org/10.1016/0006-8993(85)90412-3Get rights and content

Abstract

Substance P is a putative mediator of neurogenic inflammation, where it is postulated to be released from nerve terminals in the skin in response to noxious and electrical stimulation. To demonstrate release of substance P from cutaneous nerve terminals a blister model has been established. Electrical stimulation of the sciatic nerve for 20 min at 50 V, 15 Hz, 0.5 ms, resulted in a significant increase in substance P-like immunoreactivity (SPLI) in blister fluid, which was abolished after neonatal pretreatment of rats with capsaicin. There was no increase of SPLI, following stimulation of the sciatic nerve at 4 V. There was a corresponding decrease in skin SPLI following nerve stimulation at 50 V. Characterization of blister fluid SPLI after stimulation at 50 V demonstrated a peak of immunoreactivity, which co-eluted with synthetic substance P and SPLI from rat skin. These results confirm the hypothesis that electrical stimulation results in release of substance P from nerve terminals in the skin, and therefore fulfils an important criterion of its role as a mediator of neurogenic inflammation.

Reference (29)

  • BurgessP.R. et al.

    Cutaneous mechanoreceptors and nociceptors

  • ForemanJ. et al.

    Histamine release and vascular changes induced by neuropeptides

    Agents and Actions

    (1983)
  • GamseR. et al.

    Decrease of substance P in primary afferent neurons and impairment of neurogenic plasma extravasation by capsaicin

    Brit. J. Pharmacol.

    (1980)
  • HelmeR.D. et al.

    Substance P in the central nervous system

    Clin. exp. Neurol.

    (1981)
  • Cited by (130)

    • Inflammation and activity augment brain-derived neurotrophic factor peripheral release

      2016, Neuroscience
      Citation Excerpt :

      BDNF release is often accompanied by other neurotransmitters including glutamate, substance P (SP), somatostatin, calcitonin gene-related peptide (CGRP), etc. in facilitation of spinal cord plasticity (Tonra et al., 1998; Lever et al., 2001; Luo et al., 2001; Ng et al., 2007; Ha et al., 2008). Peripheral release of CGRP and SP has been reported (White and Helme, 1985; Kilo et al., 1997). However, little information is known about peripheral release of BDNF.

    • Neurogenic Mechanisms in Arthritis

      2009, NeuroImmune Biology
      Citation Excerpt :

      These findings indicate that bilateral alteration in spinal and primary afferent neuronal phenotype is accompanied by bilateral activation of primary afferent neurons and the generation of antidromic activity that may initiate or contribute to the remote inflammatory effects seen in clinical and experimental arthritis and inflammation. Significant spontaneous antidromic activity is seen in homologous contralateral afferents at a frequency known to result in neuropeptide release [139] and it is therefore likely that this neuronal activity contributes to the sustained neurogenic inflammation seen in experimental models. Indeed, very early in the process of arthritis when a single joint is inflamed but there are no obvious signs of remote joint disease, but when spontaneous and evoked DRRs can be recorded, the vasculature in the contralateral joint is more permeable to albumin-bound Evans blue [137].

    • AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors

      2008, Neuropharmacology
      Citation Excerpt :

      Moreover, AM404 acts at sites other than the endocannabinoid system, including transient receptor potential vanilloid 1 (TRPV1), calcium and sodium channels (Zygmunt et al., 2000; Nicholson et al., 2003; Kelley and Thayer, 2004). Small-diameter primary afferent fibres not only transmit nociceptive messages to central neurons, but are also involved in inflammatory response, such as peripheral neurogenic inflammation (White and Helme, 1985). Following noxious stimulation, these fibres release substance P (SP) and calcitonin gene-related peptide (CGRP), related to oedema and plasma leakage (Basile et al., 1993).

    • Paracrine-like excitation of low-threshold mechanoceptive C-fibers innervating rat hairy skin is mediated by substance P via NK-1 receptors

      2008, Brain Research Bulletin
      Citation Excerpt :

      Some neuropeptides, such as substance P (SP), are richly distributed in thinly myelinated and unmyelinated primary afferents (Aδ- and C-fibers, respectively) [25]. When released from peripheral terminals following antidromic electrical stimulation [45], noxious stimulation [17] or some chemical stimulants [42], these neuropeptides, especially SP and calcitonin gene-related peptide (CGRP), diffuse through the surrounding tissues and contribute to the occurrence of neurogenic inflammation [20,29], and the sensitization of sensory receptors, producing ‘allodynia’ and ‘primary hyperalgesia’ [18–20,28]. Through this mechanism, nociceptive afferent nerve fibers carry out efferent functions that affect targets carrying receptors for these neuropeptides in the periphery.

    View all citing articles on Scopus
    View full text